Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells

Immunology Letters

Volumn 93, Issue 2-3, 2004, Pages 151-158

  Qi, Chun Jian ^a,b   Zheng, Lu ^a,c   Zhou, Xuan ^a   Tao, Yi ^a   Ge, Yan ^a   Zhuang, Yu Mei ^a   Xu, Yin ^a   Yu, GeHua ^a   Zhang, Xue Guang ^a,b  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b E institutes of Shanghai   (China)

^c Changzhou the First Renmin Hospital   (China)

Author keywords

CD40; IL 6; Multiple myeloma

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL AGGREGATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MULTIPLE MYELOMA; MYELOMA CELL; PHOSPHORYLATION; PRIORITY JOURNAL; TUMOR IMMUNOLOGY; UPREGULATION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CROSS-LINKING REAGENTS; FLOW CYTOMETRY; HUMANS; IMMUNOPRECIPITATION; INTERLEUKIN-6; MODELS, BIOLOGICAL; MULTIPLE MYELOMA; PHOSPHORYLATION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2442698682     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.03.004     Document Type: Article

References (36)

1. Schonbeck U., Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci. 58:2001;4-43
2. Kooten C., Banchereau J. CD40-CD40 ligand. J Leuk Biol. 67:2000;2-17
3. Kooten C.V., Banchereau J. Immune regulation by CD40-CD40L interactions-2. Front Biosci. 5:2000;880-893
4. Diehl L., Den Boer A.T., van der Voort E.I., Melief C.J., Offringa R., Toes R.E. The role of CD40 in peripheral T cell tolerance and immunity. J Mol Med. 78:2000;363-371
5. Young L.S., Eliopoulos A.G., Gallagher N.J., Dawson C.W. CD40 and epithelial cells: across the treat divide. Immunol Today. 19:1998;502-506
6. Urashima M., Chauhan D., Uchiyama H., Freeman G.J., Anderson K.C. CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood. 85:1995;1903-1912
7. Pellat-Deceunynck C., Amiot M., Robillard N., Wijdenes J., Bataille R. CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation. Cancer Res. 56:1996;1909-1916
8. Bergamo A., Bataille R., Pellat-Deceunynck C. CD40 and CD95 induce programmed cell death in the human myeloma cell line XG2. Br J Haematol. 97:1997;652-655
9. Stevenson K.F., Anderson K. Preparing the ground for vacination against multiple myeloma. Immunol Today. 21:2000;170-171
10. Klein B., Zhang X.G., Jourdan M., Content J., Houssiau F., Aarden L., Piechaczyk M, Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood. 73:1989;517-523
11. Westendorf J.J., Ahmann G.J., Armitage R.J., Armitage R.J., Spriggs M.K., Lust J.A., Greipp P.R., Katzmann J.A., Jelinek D.F. CD40 expression in malignant plasma cells. J Immunol. 152:1994;117-128
12. Teoh G., Tai Y.T., Urashima M., Shirahama S., Matsuzaki M., Chauhan D., Treon S.P., Raje N., Hideshima T., Shima Y., Anderson K.C. CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell lines. Blood. 95:2000;1039-1046
13. Tai Y.T., Podar K., Gupta D., Lin B., Young G., Anderson K.C. CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cells. Blood. 99:2002;1419-1427
14. Pham L.V., Tamayo A.T., Yoshimura L.C., Lo P., Terry N., Reid P.S., Ford R.J. A CD40 signalosome anchored in lipid rafts leads to constitutive activation of NF-κB and autonomous cell growth in B cell lymphomas. Immunity. 16:2002;37-50
15. Tong A.W., Zhang B.Q., Mues G., Solano M., Hanson T., Stone M.J. Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro. Blood. 84:1994;3026-3033
16. Zhou Z.H., Wang J.F., Wang Y.D., Qiu Y.H., Pan J.Z., Xie W., Jiang L.Y., Klein B., Zhang X.G. An agonist anti-human CD40 monoxlonal antiboky that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line. Hybridoma. 18:1999;471-478
17. Zhang X.G., Gaillard J.P., Robillard N., Lu Z.Y., Gu Z.J., Jourdan M., Boiron J.M., Bataille R., Klein B. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood. 83:1994;3654-3663
18. Tomeczkowski J., Beilken A., Frick D., Wieland B., Konig A., Falk M.H., Reiter A., Welte K., Sykora K.W. Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells. Blood. 86:1995;1469-1480
19. Zhang X.G., Olive D., Devos J., Rebouissou C., Ghiotto R.M., Ferlin M., Klein B. Malignant plasma cell lines express a functional CD28 molecule. Leukemia. 12:1998;610-618
20. Grell M., Zimmermann G., Gottfried E., Chen C.M., Grunwald U., Huang D.C., Wu Y.H., Durkop H., Engelmann H., Scheurich P., Wajant H., Strasser A. Induction of cell death by tumor necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J. 18:1999;3034-3043
21. Los M., Wesselborg S., Klaus S.O. The role of caspases in development immunity, and apoptosis signal transduction: lessons from knockout mice. Immunity. 10:1999;629-639
22. Gravestein L.A., Borst J. Tumor necrosis factor receptor family members in the immune system. Semin Immunol. 10:1998;423-434
23. Garrone P., Neidhardt E.M., Garcia E., Galibert L., Kooten C., Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med. 182:1995;1265-1273
24. Chan F.K., Slegel R.M., Lenarko M.J. Signaling by the TNF receptor superfamily and T cell homeostasis. Immunity. 13:2000;419-422
25. Tong A.W., Seamour B., Chen J., Su D., Ordonez G., Frase L., Netto G., Stone M.J. CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells. Leuk Lymphoma. 36:2000;543-558
26. Gearling A.J., Beckett P., Christondulou M., Churchill M., Clements J., Davidson A.H., Drummond A.H., Galloway W.A., Gilbert R., Gordon J.L. Processing of tumor necrosis factor-α precursor by metalloproteinases. Nature. 370:1994;555-557
27. Alexopolou L., Pasparakis M., Kollias G. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by co-operative p55/p75 TNF receptor signaling. Eur J Immunol. 27:1997;2588-2592
28. Kusters S., Tiegs G., Alexopolou L., Pasparakis M., Douni E., Kunstle G., Bluethmann H., Wendel A., Pfizenmaier K., Kollias G., Grell M. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol. 27:1997;2870-2875
29. Wassenaar A., Verschoor T., Kievits F., Den Hartog M.T., Kapsenberg M.L., Everts V., Snijders A. CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts. Clin Exp Immunol. 115:1999;161-167
30. Mccawley L.J., Matrisian L.M. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today. 6:2000;149-156
31. Dekkers P., Lauw F.N., Hove T.T., te Velde A.A., Lumley P., Becherer D., van Deventer S.J., van der Poll T. The effect of a metalloproteinase inhibitor (GI5402) on tumor necrosis factor-alpha (TNFα) and TNFα receptors during human endotoxemia. Blood. 94:1999;2252-2258
32. Eliopoulos A.G., Davies C., Knox P.G., Gallagher N.J., Afford S.C., Adams D.H., Young L.S. CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily. Mol Cell Biol. 20:2000;5503-5515
33. Ruuls S.R., Hoek R.M., Ngo V.N., Mcneil T., Lucian L.A., Janatpour M.J., Korner H., Scheerens H., Hessel E.M., Cyster J.G., Mcevoy L.M., Sedgweck J.D. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity. 15:2001;533-543
34. Levi E., Pfeifer W.M., Kadin M.E. CD30-activation-cediated growth inhibition of anaplastic large-cell lymphoma cell lines: apoptosis or cell-cycle arrest? Blood. 98:2001;1630-1631
35. Mir S.S., Richter B., Duckett C.S. Strength of CD30 signal determines sensitivity to apoptosis. Blood. 98:2001;1631-1632
36. Gado K., Pallinger E., Kovacs P., Takacs E., Szilvasi I., Toth B.E., Nagy G., Domjan G., Falus A. Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266. Immunol Lett. 82:2002;191-196